 |
PDBsum entry 3hl7
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of human p38alpha complexed with sd-0006
|
|
Structure:
|
 |
Mitogen-activated protein kinase 14. Chain: a. Synonym: mitogen-activated protein kinase p38 alpha, map kinase p38 alpha, cytokine suppressive anti-inflammatory drug-binding protein, csaid-binding protein, csbp, max-interacting protein 2, map kinase mxi2, sapk2a. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: csbp, csbp1, csbp2, cspb1, mapk14, mxi2, thp-1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.88Å
|
R-factor:
|
0.200
|
R-free:
|
0.228
|
|
|
Authors:
|
 |
H.-S.Shieh,R.G.Kurumbail,R.A.Stegeman,J.M.Williams
|
|
Key ref:
|
 |
L.Xing
et al.
(2009).
Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Biochemistry,
48,
6402-6411.
PubMed id:
|
 |
|
Date:
|
 |
|
26-May-09
|
Release date:
|
14-Jul-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q16539
(MK14_HUMAN) -
Mitogen-activated protein kinase 14 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
360 a.a.
336 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.24
- mitogen-activated protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Biochemistry
48:6402-6411
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
|
|
L.Xing,
H.S.Shieh,
S.R.Selness,
R.V.Devraj,
J.K.Walker,
B.Devadas,
H.R.Hope,
R.P.Compton,
J.F.Schindler,
J.L.Hirsch,
A.G.Benson,
R.G.Kurumbail,
R.A.Stegeman,
J.M.Williams,
R.M.Broadus,
Z.Walden,
J.B.Monahan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
PH-797804 is a diarylpyridinone inhibitor of p38alpha mitogen-activated protein
(MAP) kinase derived from a racemic mixture as the more potent atropisomer (aS),
first proposed by molecular modeling and subsequently confirmed by experiments.
On the basis of structural comparison with a different biaryl pyrazole template
and supported by dozens of high-resolution crystal structures of p38alpha
inhibitor complexes, PH-797804 is predicted to possess a high level of
specificity across the broad human kinase genome. We used a structural
bioinformatics approach to identify two selectivity elements encoded by the
TXXXG sequence motif on the p38alpha kinase hinge: (i) Thr106 that serves as the
gatekeeper to the buried hydrophobic pocket occupied by 2,4-difluorophenyl of
PH-797804 and (ii) the bidentate hydrogen bonds formed by the pyridinone moiety
with the kinase hinge requiring an induced 180 degrees rotation of the
Met109-Gly110 peptide bond. The peptide flip occurs in p38alpha kinase due to
the critical glycine residue marked by its conformational flexibility.
Kinome-wide sequence mining revealed rare presentation of the selectivity motif.
Corroboratively, PH-797804 exhibited exceptionally high specificity against MAP
kinases and the related kinases. No cross-reactivity was observed in large
panels of kinase screens (selectivity ratio of >500-fold). In cellular
assays, PH-797804 demonstrated superior potency and selectivity consistent with
the biochemical measurements. PH-797804 has met safety criteria in human phase I
studies and is under clinical development for several inflammatory conditions.
Understanding the rationale for selectivity at the molecular level helps
elucidate the biological function and design of specific p38alpha kinase
inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Cuadrado,
and
A.R.Nebreda
(2010).
Mechanisms and functions of p38 MAPK signalling.
|
| |
Biochem J,
429,
403-417.
|
 |
|
|
|
|
 |
D.Huang,
T.Zhou,
K.Lafleur,
C.Nevado,
and
A.Caflisch
(2010).
Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
|
| |
Bioinformatics,
26,
198-204.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |